This trial is active and currently recruiting.
How to Participate
For more information, call 303.398.1443 or complete the form below.
Who Can Participate
Adults with moderate to severe asthma that is not well controlled by other therapies may be eligible to participate. Any additional medications the patient is taking need to have been a stable part of their regimen for at least three months. Additional medications should include at least a medium dose of an inhaled glucocorticoid, such as Advair Diskus or Symbicort, and at least one additional asthma-control medication.
Estimated Time Commitment
7 1/2 months
Study participation will last for approximately seven and a half months, including 15 screening days, a pre-randomization period of 30 days, administration of the investigational medication or placebo over three months, and three months to evaluate treatment effects and perform safety assessments. Participants will complete 15 visits totaling about 20 hours.